⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL669753 | 1.00 | — | — | |
| SCHEMBL12501794 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL9109908 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL5206725 | 0.97 | — | — | |
| SCHEMBL26647573 | 0.84 | CA2 (0.36) | — | |
| SCHEMBL5271914 | 0.82 | — | — | |
| SCHEMBL7947743 | 0.78 | OPRM1 (0.50) | — | |
| SCHEMBL6734023 | 0.78 | OPRM1 (0.41) | — | |
| SCHEMBL18829419 | 0.78 | — | — | |
| SCHEMBL4830064 | 0.78 | PIK3CD (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 184 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3394017-A1 | METHOD FOR PREPARING 2,3,3,3-TETRAFLUORO-1-PROPENE AND RECYCLING 2-CHLORO-3,3,3-TRIFLUOROPROPENE FREE OF IMPURITIES | Arkema France (FR) | 2018-10-31 | — | — | EP | claimed |
| WO-2017108518-A1 | METHOD FOR PREPARING 2,3,3,3-TETRAFLUORO-1-PROPENE AND RECYCLING 2-CHLORO-3,3,3-TRIFLUOROPROPENE FREE OF IMPURITIES | ARKEMA FRANCE (FR) | 2017-06-29 | — | — | WO | claimed |
| EP-2592070-B1 | Tetrazole-substituted arylamides | HOFFMANN LA ROCHE (CH) | 2016-08-31 | — | — | EP | claimed |
| WO-2010075197-A1 | KINASE INHIBITORS | ALLERGAN, INC. (US) | 2010-07-01 | — | — | WO | claimed |
| EP-2099757-A2 | SULFOXIMINES AS KINASE INHIBITORS | Allergan, Inc. (US) | 2009-09-16 | — | — | EP | claimed |
| WO-2008061236-A2 | SULFOXIMINES AS KINASE INHIBITORS | ALLERGAN, INC. (US) | 2008-05-22 | — | — | WO | claimed |
| EP-1430048-A1 | 3-(ARYLAMINO)METHYLENE-1, 3-DIHYDRO-2H-INDOL-2-ONES AS KINASE INHIBITORS | Allergan, Inc. (US) | 2004-06-23 | — | — | EP | claimed |
| WO-2003027102-A1 | 3-(ARYLAMINO)METHYLENE-1, 3-DIHYDRO-2H-INDOL-2-ONES AS KINASE INHIBITORS | ALLERGAN, INC. (US) | 2003-04-03 | — | — | WO | claimed |
| US-12398097-B2 | WDR5-MYC inhibitors | VANDERBILT UNIVERSITY (US) | 2025-08-26 | — | — | US | disclosed |
| EP-4583870-A2 | MITOCHONDRIAL UNCOUPLERS FOR TREATMENT OF METABOLIC DISEASES AND CANCER | Mito Biopharma, LLC (US) | 2025-07-16 | — | — | EP | disclosed |
| US-20250161281-A1 | EMOPAMIL-BINDING PROTEIN INHIBITORS AND USES THEREOF | BIOGEN MA INC. | 2025-05-22 | — | — | US | disclosed |
| US-20240405281-A1 | Rechargeable Divalent Metal Batteries Having Fast Interfacial Charge Transfer Kinetics | UNIVERSITY OF MARYLAND, COLLEGE PARK (US) | 2024-12-05 | — | — | US | disclosed |
| US-20240279241-A1 | PYRIDO[4,3-D]PYRIMIDINE COMPOUNDS CAPABLE OF INHIBITING KRAS MUTANT PROTEINS | REDX PHARMA PLC (GB) | 2024-08-22 | — | — | US | disclosed |
| WO-2024054766-A2 | MITOCHONDRIAL UNCOUPLERS FOR TREATMENT OF METABOLIC DISEASES AND CANCER | MITO BIOPHARMA, LLC (US) | 2024-03-14 | — | — | WO | disclosed |
| EP-0254183-A2 | 2,4-Diaminopyrimidines | BAYER AG (DE) | 1988-01-27 | — | — | EP | disclosed |
| EP-0230244-A2 | 2,4-Diamino-6-halogenoalkyl pyrimidines | BAYER AG (DE) | 1987-07-29 | — | — | EP | disclosed |
| US-4627872-A | HERBICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1986-12-09 | — | — | US | disclosed |
| EP-0184752-A2 | 2,4-Diaminopyrimidines | BAYER AG (DE) | 1986-06-18 | — | — | EP | disclosed |
| EP-0010256-B1 | PROCESS FOR PREPARING SYMMETRIC 1,3-DISUBSTITUTED UREAS | BASF Aktiengesellschaft (DE) | 1982-12-29 | — | — | EP | disclosed |
| EP-0010256-A2 | Process for preparing symmetric 1,3-disubstituted ureas | BASF Aktiengesellschaft (DE) | 1980-04-30 | — | — | EP | disclosed |